Biomarkers are needed to light the way in research and therapy development

Posted on Sunday, July 1, 2012 - 09:45, By: Other
An urgent need exists for biomarkers — biological indicators — in ALS research that can be used:

New mice, new projects and a newly added area of emphasis have been added to ALS TDI's preclinical drug development repertoire

Posted on Thursday, July 1, 2010 - 15:09, By: Amy Madsen
In continuing efforts to refine its preclinical drug development program, the ALS Therapy Development Institute (ALS TDI) of Cambridge, Mass., has added a new research mouse model to its operations, along with two new projects aimed at helping researchers test and develop therapies in the new mouse.

ALS TDI's May 2010 research update addressed changes: a new mouse model, new projects, a paradigm shift and a model for faster drug development

Posted on Tuesday, June 1, 2010 - 13:52, By: Amy Madsen
In its quarterly Research Update Webcast on May 18, 2010, the ALS Therapy Development Institute (ALS TDI) informed viewers of a "paradigm shift" in TDI research. The changes include the addition of a new mouse model to the Institute's preclinical drug development program and an increased...
Posted on Sunday, March 1, 2009 - 09:16, By: Margaret Wahl
Investigators are looking for an ALS-specific “profile” in blood and spinal-fluid samples.